Navigation Links
RxISK Seeks Reports from AbbVie Customers as part of campaign launched today by Dr. David Healy
Date:7/15/2013

Toronto, Canada (PRWEB) July 15, 2013

RxISK.org, the first free independent website for researching and reporting prescription drug side effects, is helping a campaign to capture patient reported side effects of a range of drugs sold by the pharmaceutical company AbbVie - the recent spun-off entity of Abbott Laboratories.

The campaign was announced by Dr. David Healy, a leading drug safety advocate and psychopharmacologist, in his recent blog post on DavidHealy.org.

As reported in the PharmaTimes May 1, 2013, AbbVie and InterMune sued the European Medicines Agency (EMA) to prevent the release of data and obtained an interim injunction to prevent the release. Bloomberg reports July 12, 2013, that this interim decision is being appealed by EMA.

(Interim decision see C-389/13 P, EMA v. AbbVie, C-390/13 P, EMA v. InterMune U.K. and Others.)

"Since most drugs are marketed and used globally this data could have global significance," says Dr. Healy. Healy is among the growing group of high profile advocates for access to complete data.

Dr. Healy says, “data transparency would be an important first step in helping patients and their doctors make informed decisions on the benefits and risks of prescription medicines by enabling independent validation. We urge everyone to make their voices heard on this issue”.

“Side effects know no borders and in this campaign we want to use RxISK.org to collect patient reports about their experiences on AbbVie drugs from every corner of the planet. We will share these results with everyone – including AbbVie,” says Healy.

AbbVie drugs include:
Humira
Depakote
Kaletra (for HIV/AIDs)
Androgrel (for low Testosterone)
Lupron used (for prostate cancer, breast cancer and endometriosis)
Esbriet

RxISK — your megaphone to help change drug safety
RxISK.org allows users to enter the name of a prescription drug and see the side effects that have been reported to the FDA since 2004, as well as to RxISK, for more than 35,000 drug names from 103 countries. The data is presented in tables, tag clouds, heat maps, and interactive graphs, showing what’s happening with other people taking the same drug around the world.

Users can then select the effect(s) they are experiencing and click on Report a Drug Side Effect to complete a report. They get a personalized RxISK Report linking their symptoms and meds, which they can take to their doctor or pharmacist to facilitate a better treatment conversation. This will also add their anonymized experience to the RxISK database so that others can benefit from this information.

About Data Based Medicine Americas Ltd.
RxISk.org is owned and operated by Data Based Medicine Americas Ltd. (DBM), based in Toronto, Canada. DBM's founders have international reputations in early drug-side-effect detection and risk mitigation, pharmacovigilance, and patient-centered care. Although drug side effects are known to be a leading cause of death and disability, less than 5% of serious drug side effects are reported. DBM’s mission is to capture this missing data directly from patients through RxISK.org’s free drug side effect reporting tool and use this data to help make medicines safer for all of us.

Media contact
David Carmichael
david(dot)carmichael(at)RxISK(dot)org
+1 (647) 799-3792

Read the full story at http://www.prweb.com/releases/2013/7/prweb10927778.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. RxISK.org’s Dr. Healy Coming to Talk to U.S. Audiences About Deadly Prescription Drug Side Effects
2. Special Needs Organization Seeks Parents In Need of a Mentor
3. RundleFit Seeks Promotional Partnership with Socially Responsible, Healthy Lifestyle Brands For Their Six-Week Jump Start/Positive Incentive Program
4. Milaa Event Seeks to Improve a Child’s Academic Learning Through Outdoor Play
5. WEDI Selects Co-Chairs and Seeks Participants for New 2013 WEDI Report Workgroups
6. Announcement: American Garment Manufacturer, Nouvelle, Inc., Seeks Medical and Plastic Surgery Supply Vendors to Distribute USA-Made Compression Wear
7. Bergener & Associates: Woman Who Almost Died After Contracting Hantavirus in June 2012 Seeks Compensation
8. Life Extension Foundation Seeks Volunteers with Alzheimer's to Participate in a Clinical Trial Utilizing a Common Arthritis Drug
9. d’Oliveira & Associates Seeks Clients That Have Been Affected by the Prescription Drug Topamax
10. Eczema Nonprofit Seeks to Shine New Light on Overlooked Condition
11. hCGTreatments / Diet Doc hCG Diet and Weight Loss Plans Seeks Intellectual Property Protection for Their Prescription hCG Diets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... a clinician-based audience, will be participating in Rare Disease Day events, hosted by ... In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... leadership , media relations, content marketing, social media management, corporate communications, SEO and ... in the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing LLC announces ... and explore the world from different perspectives. By providing a place for people ... understanding, increase empathy, and find greater happiness. , "Our approach to structuring ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for Autism and ... for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. ... to see films in an environment that accommodates their unique needs. , Launched ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm ... in children aged 3-8 with Autism, is now enrolling at three new sites. These ... the United States. , “There are currently no approved drugs that address the ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 Report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2015 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/24/2017)... Australia , Feb. 23, 2017  Directors from Pharma To ... two companies have joined forces, resulting in the founding of Pharma ... Pharma To Market are pleased to announce their expansion ... office in Singapore . The company are delighted ... as Co-Director of the Singapore based entity. ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... USD 330.6 million by 2021 from USD 275.9 ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... industries, increasing spending on pharmaceutical R&D, and growth ... factors driving the market growth for particle counters. ...
Breaking Medicine Technology: